Author： Dawson Ted M.
Publisher： Informa Healthcare
ISSN： 1369-1627
Source： International Review of Psychiatry, Vol.12, Iss.4, 2000-11, pp. : 263-269
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
GDNF treatment in Parkinson’s disease: time for controlled clinical trials?
Brain, Vol. 125, Iss. 10, 2002-10 ,pp. :
Access to resources
Recommend
Clinical heterogeneity in newly diagnosed Parkinson’s disease
By Post B. Speelman J. Haan R.
Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. :
Unilateral subthalamotomy in the treatment of Parkinson’s disease
By Patel N.K. Heywood P. O’Sullivan K. McCarter R. Love S. Gill S.S.
Brain, Vol. 126, Iss. 5, 2003-05 ,pp. :
Melatonin in Parkinson's disease
By Medeiros C.
Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. :
A vaccine for Parkinson’s disease?
Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. :